TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Immunotech Biopharm Ltd ( (HK:6978) ) just unveiled an announcement.
Immunotech Biopharm Ltd announced that all proposed resolutions at its Annual General Meeting held on May 23, 2025, were passed unanimously by shareholders. The resolutions included the adoption of financial statements, re-election of directors, and authorization for the board to manage share allotments. This outcome reflects strong shareholder support and positions the company for continued strategic governance and operational stability.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. It focuses on the development and commercialization of innovative therapies, primarily targeting cancer and autoimmune diseases.
Average Trading Volume: 722,000
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.77B
For detailed information about 6978 stock, go to TipRanks’ Stock Analysis page.